Summary & Overview
CPT 81007: Urine Bacteriuria Screen, Nonculture Nondipstick
CPT code 81007 identifies a laboratory method that detects the presence or absence of bacteriuria using a nonculture, nondipstick technique on a typically random urine specimen. This code is used for rapid screening when culture-based methods are not requested, and it serves an important role in outpatient and clinical laboratory workflows where quick determinations of bacteriuria can inform further diagnostic steps.
Key payers included in coverage discussions are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and how it is classified within CPT. The publication outlines common billing considerations and related administrative elements, with benchmarks and policy updates where available. The content also highlights operational implications for laboratories and outpatient facilities, including typical use cases and limitations of a nonculture, nondipstick approach.
This national-level summary is intended to help payers, billing staff, and clinical administrators understand when CPT code 81007 is applied, what it represents clinically, and what topics—such as reimbursement benchmarks, coding guidance, and clinical relevance—are covered in the full analysis.
Billing Code Overview
CPT code 81007 describes a nonculture, nondipstick urine test used to determine the presence or absence of bacteriuria. The analyst performs a laboratory method that does not involve urine culture or chemical dipstick analysis. The specimen is typically obtained from a random urine collection.
Service type: Laboratory diagnostic test — urine bacteriuria screen (nonculture, nondipstick)
Typical site of service: Clinical laboratory or outpatient collection site
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an ambulatory clinic, urgent care, emergency department, or nursing facility with lower urinary tract symptoms such as dysuria, frequency, urgency, suprapubic discomfort, or new-onset urinary incontinence. A clinician or nurse collects a random (voided) urine specimen and submits it for a nonculture, nondipstick assay to detect bacteriuria (e.g., automated urinalysis instrument or urine turbidity/flow cytometry screening). The workflow commonly includes specimen labeling, transport to the point-of-care testing device or central laboratory, performance of the nonculture test, documentation of the result in the medical record, and clinician interpretation to guide decisions about further testing (urine culture CPT 82075) or empiric therapy. Typical sites of service are outpatient clinics, urgent care centers, hospital emergency departments, and skilled nursing facilities where rapid screening for bacteriuria is needed prior to definitive culture or treatment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies |
11 |